SCHEMBL1624948

SCHEMBL1624948

Cc1ccc(N)c(NC(=O)c2cc(Br)ccc2Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
GAA P10253 2/20 0.55
POLB P06746 1/20 0.55
RECQL P46063 1/20 0.55
RAB9A P51151 2/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 1/20 0.52
HDAC1 Q13547 1/20 0.51
TSHR P16473 1/20 0.50
PKM P14618 1/20 0.48
LMNA P02545 1/20 0.48
RORC P51449 1/20 0.48
KDM4E B2RXH2 1/20 0.48
ATM Q13315 1/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13050490 0.90 KMT2A (0.57) MAPTGAAPOLBRAB9AKMT2A
SCHEMBL1283839 0.84 MAPT (0.55) MAPTGAAPOLBRECQLKMT2A
SCHEMBL28880754 0.82 MAPT (0.66) MAPTGAAPOLBRECQLRAB9A
SCHEMBL1284645 0.75 NPC1 (0.52) GAARAB9AKMT2ASMN1; SMN2HDAC1
SCHEMBL733872 0.74 CYP2C19 (0.58) MAPTGAAPOLBRECQLRAB9A
SCHEMBL29978583 0.74 MAPT (0.70) MAPTGAAPOLBRECQLRAB9A
SCHEMBL28341354 0.74 MAPT (0.70) MAPTGAAPOLBRECQLRAB9A
SCHEMBL11207191 0.73 HDAC1 (0.60) MAPTPOLBRAB9AKMT2ASMN1; SMN2
SCHEMBL30832967 0.73 HDAC1 (0.60) MAPTPOLBRAB9AKMT2ASMN1; SMN2
SCHEMBL7517172 0.73 PLAU (0.50) MAPTGAAPOLBRECQLHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835648-B2 Hedgehog pathway antagonists and therapeutic applications thereof SIENA BIOTECH S.P.A. (IT) 2014-09-16 US disclosed
US-8835648-B2 Hedgehog pathway antagonists and therapeutic applications thereof SIENA BIOTECH S.P.A. (IT) 2014-09-16 US disclosed
US-20120088752-A1 HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF SIENA BIOTECH S.P.A. (IT) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088752-A1 HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF SHH, GLI1, SMO MAPT 3104/4885GAA 2515/4885POLB 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.